Other researchers have proposed an anti-tumor vaccine based on a proton-driven deformable nano-delivery system, which not only efficiently delivers antigen peptides into the cytoplasm of immune cells, but also enhances the innate immune system by acting as an adjuvant to activate the NLRP3. This evidence concerns the gene NLRP3 and neoplasm.